Answers are grounded in this paper and cite their sources.
This review highlights worse outcomes after discontinuing RASi in chronic kidney disease, indicating more careful management is needed.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lecea et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: